Setting a New Standard in Supportive Care
Our company was founded by a multidisciplinary team who came together to rethink how Oral Mucositis is treated, using technology to deliver a therapy with consistency, accuracy, and outcomes clinicians can trust. Such precise, personalized medicine should not be optional- it should be the standard.
Our mission
We're on a mission to set a new standard in supportive care through scientifically optimized light therapies that are personalized for each patients' specific physiology and tissue to unlock their full therapeutic potential to eliminate oral mucositis in patients undergoing life-saving cancer treatment.
Our vision
Our vision is to make effective, accessible, and evidence-based light therapies available to every patient at risk of oral mucositis so that it will no longer limit recovery, quality of life, or treatment outcomes. This will transform supportive cancer care and improve the treatment journey for patients worldwide.
Our team
Our team combines decades of experience and expertise in photonics, medical device technology, clinical development, product commercialization, and translational research- a powerful mix to advance our light therapy from laboratory to the clinic and ultimate commercialization.
Tal Offer PhD
Founder and Chief Scientific Officer
Paul Sanders
Founder and Strategic Advisor
Gal Shafirstein DSc
Founder and Clinical Advisor